Liu Guangyang, Wang Herui, Li Xin, Mi Yi, Zhang Chenliang, Chen Yaoyao, Miao Li, Long Haomiao, He Jun, Ge Qinggang, Liu Yongjun
Stem Cell Biology and Regenerative Medicine Apartment, Yi-Chuang Institute of Bio-Industry, Beijing, China.
Centre for Safety Evaluation and Research of Drugs, Institute of Laboratory Animal Sciences, Chinese Academy of Medical Science, Beijing, China.
Future Sci OA. 2025 Dec;11(1):2471723. doi: 10.1080/20565623.2025.2471723. Epub 2025 Mar 4.
This study aims to investigate the biodistribution and persistence of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) in NCG mice post-intravenous injection, utilizing Zr-PET/CT, bioluminescence imaging, multiplex immunohistochemistry (mIHC), and quantitative polymerase chain reaction (qPCR).
hUC-MSCs were labeled with Zr-oxine (Zr-MSCs) or transduced with luciferase gene (Luc-MSCs). Real-time tracking of Zr-MSCs lasted for 14-days followed by mIHC staining of hCD73. Real-time tracking of Luc-MSCs lasted for 7-days, followed by mIHC staining of hCD73 and human Alu-based qPCR. All methods adhered to ICH and other regulatory guidelines for development of cell-based drugs.
A biodistribution and persistence pattern was observed in the order of lung > liver > kidney > >spleen, although discrepancies were noted for the liver and kidney.
Each method exhibited strengths and weaknesses: Zr-PET/CT enabled long-term tracking but encountered issues with Zr shedding and dead cells; bioluminescence provided specific detection but was hampered by a rapid decline in signal; mIHC identified cells but relied on antigen abundance; qPCR detected minimal cell quantities but was unable to differentiate between live and dead cells. These limitations may obscure the true fate of cells , highlighting the need for more accurate and reliable assessment techniques.
本研究旨在利用锆正电子发射断层扫描/计算机断层扫描(Zr-PET/CT)、生物发光成像、多重免疫组织化学(mIHC)和定量聚合酶链反应(qPCR),研究静脉注射后人脐带间充质干细胞(hUC-MSCs)在NCG小鼠体内的生物分布和持久性。
hUC-MSCs用锆-8-羟基喹啉(Zr-MSCs)标记或用荧光素酶基因转导(Luc-MSCs)。Zr-MSCs的实时追踪持续14天,随后对hCD73进行mIHC染色。Luc-MSCs的实时追踪持续7天,随后对hCD73进行mIHC染色和基于人Alu序列的qPCR。所有方法均符合国际人用药品注册技术协调会(ICH)及其他基于细胞的药物研发监管指南。
观察到生物分布和持久性模式为肺>肝>肾>>脾,尽管肝和肾存在差异。
每种方法都有优缺点:Zr-PET/CT能够进行长期追踪,但存在锆脱落和死细胞问题;生物发光提供特异性检测,但受信号快速下降的阻碍;mIHC可识别细胞,但依赖抗原丰度;qPCR可检测到少量细胞,但无法区分活细胞和死细胞。这些局限性可能掩盖细胞的真实命运,凸显了需要更准确可靠的评估技术。